Role of Postchemotherapy Retroperitoneal Lymph Node Dissection in Advanced Germ Cell Tumors

被引：8
|
作者：
Nguyen, Carvell T. [1 ]
Stephenson, Andrew J. [1 ]
机构：
[1] Cleveland Clin, Glickman Urol & Kidney Inst, Ctr Urol Oncol, Cleveland, OH 44195 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2011年 / 25卷 / 03期
关键词：
Testicular neoplasms; Neoplasms; Germ cell; Embryonal; Chemotherapy; Retroperitoneum; Lymph node excision; Neoplasm staging; NONSEMINOMATOUS TESTICULAR CANCER; EUROPEAN CONSENSUS CONFERENCE; POSITRON-EMISSION-TOMOGRAPHY; RESIDUAL MASSES; OUTCOME ANALYSIS; MALIGNANT-TRANSFORMATION; COMBINATION CHEMOTHERAPY; SURGICAL RESECTION; THORACIC MASSES; SALVAGE SURGERY;
D O I：
10.1016/j.hoc.2011.03.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Advanced germ cell tumors (GCTs) are curable with the appropriate integration of cisplatin-based chemotherapy and postchemotherapy surgical resection of residual masses. For men with retroperitoneal metastases, postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) is a vital component of this treatment algorithm. The rationale for PC-RPLND is based on the consistent 10% to 20% and 35% to 55% incidence of viable malignancy and teratoma, respectively. Prognostic factors and nomograms cannot predict the presence of necrosis with sufficient accuracy to obviate the need for PC-RPLND. This article reviews the indications, technique, and outcomes of PC-RPLND in the management of advanced GCT.
引用
收藏
页码：593 / +
页数：13
相关论文
共 50 条
  • [21] POSTCHEMOTHERAPY ROBOTIC-ASSISTED LAPAROSCOPIC RETROPERITONEAL LYMPH NODE DISSECTION FOR TESTICULAR GERM CELL TUMOURS
    Castillo, O. A.
    Sepulveda, F.
    Rubio, G. A.
    Landerer, E.
    Vidal, I.
    Campos, R.
    Foneron, A.
    Gomez, R.
    JOURNAL OF ENDOUROLOGY, 2010, 24 : A241 - A241
  • [22] Vena Caval Reconstruction During Postchemotherapy Retroperitoneal Lymph Node Dissection for Metastatic Germ Cell Tumor
    Ehrlich, Yaron
    Kedar, Daniel
    Zelikovski, Avigdor
    Konichezky, Miriam
    Baniel, Jack
    UROLOGY, 2009, 73 (02) : 442.e17 - 442.e19
  • [23] COMPLICATIONS OF POSTCHEMOTHERAPY RETROPERITONEAL LYMPH-NODE DISSECTION
    BANIEL, J
    FOSTER, RS
    ROWLAND, RG
    BIHRLE, R
    DONOHUE, JP
    JOURNAL OF UROLOGY, 1995, 153 (03): : 976 - 980
  • [24] Retroperitoneal lymph node dissection for germ cell tumour
    Tran, Vy
    Gibson, Luke
    Sengupta, Shomik
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (06) : 3103 - 3111
  • [25] Laparoscopic and robotic postchemotherapy retroperitoneal lymph node dissection
    Kunit, Thomas
    Janetschek, Guenter
    CURRENT OPINION IN UROLOGY, 2014, 24 (02) : 162 - 167
  • [26] Quality reporting in postchemotherapy retroperitoneal lymph node dissection
    Daneshmand, Siamak
    CANCER, 2020, 126 (22) : 4825 - 4825
  • [27] Postchemotherapy retroperitoneal lymph node dissection for testis cancer
    Risk, Michael C.
    Foster, Richard S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (01) : 95 - 106
  • [28] What are the indications for postchemotherapy retroperitoneal lymph node dissection?
    Einhorn, L. H.
    Foster, R. S.
    ANNALS OF ONCOLOGY, 2014, 25 (02) : 301 - 303
  • [29] Comparing the perioperative management of postchemotherapy retroperitoneal lymph node dissection (PCRPLND) in patients with pure seminomatous and nonseminomatous germ cell tumors (NSGCT)
    Pfister, D. J.
    Busch, J.
    Winter, C.
    Schrader, M.
    Dieckmann, K.
    Schmelz, H. U.
    Albers, P.
    Heidenreich, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [30] Orthotopic renal autotransplantation: A step forward during postchemotherapy retroperitoneal lymph node dissection for germ cell tumor
    Mor, Akash
    Gujela, Ajit
    Patel, Sachin
    Kumar, Vineet
    Prakash, Gagan
    INDIAN JOURNAL OF UROLOGY, 2024, 40 (04) : 273 - 275
12345